A carregar...
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and...
Na minha lista:
| Publicado no: | J Cachexia Sarcopenia Muscle |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989756/ https://ncbi.nlm.nih.gov/pubmed/29542279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12292 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|